Marek Staszewski - Search Results

Year	Number of Results
2012	2
2013	1
2015	1
2016	1
2018	1
2019	2
2021	1
2022	1
2023	2
2024	2

1

Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial.

Tajstra M, Dyrbuś M, Rutkowski T, Składowski K, Sosnowska-Pasiarska B, Góźdź S, Radecka B, Staszewski M, Majsnerowska A, Myrda K, Nowowiejska-Wiewióra A, Skoczylas I, Rymkiewicz I, Niklewski T, Nowak J, Przybyłowski P, Gąsior M, Jarząb M. Tajstra M, et al. Among authors: staszewski m. ESC Heart Fail. 2023 Oct;10(5):3174-3183. doi: 10.1002/ehf2.14466. Epub 2023 Jul 14. ESC Heart Fail. 2023. PMID: 37449716 Free PMC article.

2

Loratadine analogues as MAGL inhibitors.

Patel JZ, Ahenkorah S, Vaara M, Staszewski M, Adams Y, Laitinen T, Navia-Paldanius D, Parkkari T, Savinainen JR, Walczyński K, Laitinen JT, Nevalainen TJ. Patel JZ, et al. Among authors: staszewski m. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1436-42. doi: 10.1016/j.bmcl.2015.02.037. Epub 2015 Feb 24. Bioorg Med Chem Lett. 2015. PMID: 25752982

3

Synthesis and Biological Evaluation of Thiazole-Based Derivatives with Potential against Breast Cancer and Antimicrobial Agents.

Pivovarova E, Climova A, Świątkowski M, Staszewski M, Walczyński K, Dzięgielewski M, Bauer M, Kamysz W, Krześlak A, Jóźwiak P, Czylkowska A. Pivovarova E, et al. Among authors: staszewski m. Int J Mol Sci. 2022 Aug 30;23(17):9844. doi: 10.3390/ijms23179844. Int J Mol Sci. 2022. PMID: 36077257 Free PMC article.

4

Guanidines: Synthesis of Novel Histamine H₃R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect.

Staszewski M, Iwan M, Werner T, Bajda M, Godyń J, Latacz G, Korga-Plewko A, Kubik J, Szałaj N, Stark H, Malawska B, Więckowska A, Walczyński K. Staszewski M, et al. Pharmaceuticals (Basel). 2023 Apr 30;16(5):675. doi: 10.3390/ph16050675. Pharmaceuticals (Basel). 2023. PMID: 37242458 Free PMC article.

5

Preliminary studies of 1,5-benzoxazepine derivatives as potential histamine H₃ receptor antagonists.

Stefaniak-Napieralska M, Walczyński K, Iwan M, Korga-Plewko A, Szałaj N, Więckowska A, Staszewski M. Stefaniak-Napieralska M, et al. Among authors: staszewski m. Future Med Chem. 2024 Feb;16(3):197-204. doi: 10.4155/fmc-2023-0277. Epub 2024 Jan 8. Future Med Chem. 2024. PMID: 38189171

6

4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases.

Michalska B, Dzięgielewski M, Godyń J, Werner T, Bajda M, Karcz T, Szczepańska K, Stark H, Więckowska A, Walczyński K, Staszewski M. Michalska B, et al. Among authors: staszewski m. ACS Chem Neurosci. 2024 Mar 20;15(6):1206-1218. doi: 10.1021/acschemneuro.3c00800. Epub 2024 Mar 5. ACS Chem Neurosci. 2024. PMID: 38440987 Free PMC article.

7

Guanidine Derivatives: How Simple Structural Modification of Histamine H₃R Antagonists Has Led to the Discovery of Potent Muscarinic M₂R/M₄R Antagonists.

Staszewski M, Nelic D, Jończyk J, Dubiel M, Frank A, Stark H, Bajda M, Jakubik J, Walczyński K. Staszewski M, et al. ACS Chem Neurosci. 2021 Jul 7;12(13):2503-2519. doi: 10.1021/acschemneuro.1c00237. Epub 2021 Jun 8. ACS Chem Neurosci. 2021. PMID: 34100603 Free PMC article.

8

Search for multifunctional agents against Alzheimer's disease among non-imidazole histamine H3 receptor ligands. In vitro and in vivo pharmacological evaluation and computational studies of piperazine derivatives.

Jończyk J, Lodarski K, Staszewski M, Godyń J, Zaręba P, Soukup O, Janockova J, Korabecny J, Sałat K, Malikowska-Racia N, Hebda M, Szałaj N, Filipek B, Walczyński K, Malawska B, Bajda M. Jończyk J, et al. Among authors: staszewski m. Bioorg Chem. 2019 Sep;90:103084. doi: 10.1016/j.bioorg.2019.103084. Epub 2019 Jun 26. Bioorg Chem. 2019. PMID: 31271942

9

Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.

Guryn R, Staszewski M, Stasiak A, McNaught Flores D, Fogel WA, Leurs R, Walczyński K. Guryn R, et al. Among authors: staszewski m. Molecules. 2018 Feb 3;23(2):326. doi: 10.3390/molecules23020326. Molecules. 2018. PMID: 29401659 Free PMC article.

10

Design, synthesis, and in vitro and in vivo characterization of 1-{4-[4-(substituted)piperazin-1-yl]butyl}guanidines and their piperidine analogues as histamine H₃ receptor antagonists.

Staszewski M, Stasiak A, Karcz T, McNaught Flores D, Fogel WA, Kieć-Kononowicz K, Leurs R, Walczyński K. Staszewski M, et al. Medchemcomm. 2019 Jan 11;10(2):234-251. doi: 10.1039/c8md00527c. eCollection 2019 Feb 1. Medchemcomm. 2019. PMID: 30881612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year